• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Jul 21.
doi: 10.1002/jmv.27224. Online ahead of print.
Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers


Jordan Z Neises[SUP] 1 [/SUP], Md Saddam Hossain[SUP] 2 [/SUP], Rifat Sultana[SUP] 1 [/SUP], Kevin N Wanniarachchi[SUP] 1 [/SUP], Jared W Wollman[SUP] 1 [/SUP], Eric Nelson[SUP] 3 [/SUP], Bonny L Specker[SUP] 4 [/SUP], Adam D Hoppe[SUP] 2 [/SUP], Steven R Lawson[SUP] 3 [/SUP], Natalie W Thiex[SUP] 1 [/SUP]



Affiliations

Abstract

The objective of this longitudinal cohort study was to determine the seroprevalence of antibodies to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in healthcare workers employed at healthcare clinics in three rural counties in eastern South Dakota and western Minnesota from May 13, 2020 through December 22, 2020. Three blood draws were performed at five clinical sites and tested for the presence of antibodies against the SARS-CoV-2 virus. Serum samples were tested for the presence of antibodies using a fluorescent microsphere immunoassay (FMIA), neutralization of SARS-CoV-2 Spike-pseudotyped particles (SARS-CoV-2pp) assay, and serum virus neutralization (SVN) assay. The seroprevalence was determined to be 1/336 (0.29%) for samples collected from 5/13/20-7/13/20, 5/260 (1.92%) for samples collected from 8/13/20-9/25/20, and 35/235 (14.89%) for samples collected from 10/16/20-12/22/20. Eight of the 35 (22.8%) seropositive individuals identified in the final draw did not report a previous diagnosis with COVID-19. There was a high correlation (>90%) among the FMIA and virus neutralization assays. Each clinical site's seroprevalence was higher than the cumulative incidence for the general public in each respective county as reported by state public health agencies. As of December 2020, there was a high percentage (85%) of seronegative individuals in the study population. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; SARS-CoV-2; Seroprevalence; healthcare worker; rural.
 
Back
Top Bottom